Ranit Kedmi
Impact in
- Molecular Biology top 10%
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- CRISPR and Genetic Engineering
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 2
- RNA and protein synthesis mechanisms 2
- CRISPR and Genetic Engineering 2
-
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
- Co-authors
- Dan Peer (8 shared papers)Srinivas Ramishetti (3 shared papers)Daniel Rosenblum (2 shared papers)Nuphar Veiga (2 shared papers)Meir Goldsmith (2 shared papers)Mark A. Behlke (3 shared papers)Dinorah Friedmann‐Morvinski (1 shared paper)Mollie S. Schubert (1 shared paper)
- Journals
- PLoS ONE (2 papers)Biomaterials (1 paper)Science Translational Medicine (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)
- Partner nations
- IsraelUnited StatesGermany
In The Last Decade
Ranit Kedmi
12 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 1.1k
- Biomaterials 185
- Immunology 282
- Business and International Management 20
- Genetics 253
Countries citing papers authored by Ranit Kedmi
This map shows the geographic impact of Ranit Kedmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranit Kedmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranit Kedmi more than expected).
Fields of papers citing papers by Ranit Kedmi
This network shows the impact of papers produced by Ranit Kedmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranit Kedmi. The network helps show where Ranit Kedmi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ranit Kedmi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy Hit paper breakdown → | 2020 | 430 |
| 2 | 2010 | 407 | |
| 3 | 2018 | 249 | |
| 4 | 2015 | 160 | |
| 5 | 2021 | 28 | |
| 6 | 2024 | 27 | |
| 7 | 2013 | 18 | |
| 8 | 2011 | 9 | |
| 9 | 2013 | 8 | |
| 10 | 2016 | 7 | |
| 11 | 2025 | 4 | |
| 12 | 2013 | 2 |
About Ranit Kedmi
Ranit Kedmi is a scholar working on Molecular Biology, Immunology, Immunology and Allergy, Infectious Diseases and Oncology, having authored 12 papers that have together received 1.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (5 papers), Immunotherapy and Immune Responses (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), RNA and protein synthesis mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers), CRISPR and Genetic Engineering (2 papers), Immune Cell Function and Interaction (2 papers) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Molecular Biology (1.1k citations), Biomaterials (185 citations), Immunology (282 citations), Business and International Management (20 citations) and Genetics (253 citations). Ranit Kedmi has collaborated with scholars based in Israel, United States and Germany. Frequent co-authors include Dan Peer, Srinivas Ramishetti, Daniel Rosenblum, Nuphar Veiga, Meir Goldsmith, Mark A. Behlke, Dinorah Friedmann‐Morvinski, Mollie S. Schubert, Zvi R. Cohen and Judy Lieberman. Their work appears in journals such as PLoS ONE, Biomaterials, Science Translational Medicine, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.